Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

AHF unveils new national advertising campaign about AIDS drugs

AIDS Healthcare Foundation today unveiled a new national advertising campaign headlined, "There Is No Magic Pill," an advocacy and awareness campaign to educate and prompt discussion among gay men and others regarding Gilead Sciences and its likely plans to seek Food and Drug Administration approval for use of its blockbuster AIDS drug Truvada as a form a 'pre-exposure prophylaxis' to prevent HIV transmission.

10 Mar 2011

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

A team of researchers from the United States and Europe has identified a single genetic mutation in the CUBN gene that is associated with albuminuria both with and without diabetes. Albuminuria is a condition caused by the leaking of the protein albumin into the urine, which is an indication of kidney disease.

9 Mar 2011

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.

9 Mar 2011

Diabetes belt mapped out in the US

A government commissioned team of researchers has now identified a diabetes belt in the U.S. County-by-county mapping shows that the highest rates of diabetes cut two paths - one strung through Tennessee, Kentucky and West Virginia, and another running eastward from Louisiana through Mississippi, Alabama, Georgia and South Carolina. This belt also touches parts of North Carolina, Virginia, Florida, Texas, Arkansas, Ohio and Pennsylvania. High-diabetes pockets crop up in Oklahoma, Michigan, Arizona, the Dakotas and elsewhere. The belt includes 644 counties in 15 states with the highest diabetes rates.

8 Mar 2011

Lab made urinary tube going strong after six years of transplant

In a scientific breakthrough, five boys who were unable to urinate due to pelvic injury were cured for up to six years after getting new lab-grown urethras or urinary tubes that connect with the bladder. This breakthrough comes from Wake Forest University researcher Anthony Atala. It was in 2006 that the team reported the first successful implantation of lab-grown urinary bladders into humans. Today six years after the operation all of the boys continue to do well, with normal or near-normal urinary flow. The boy first treated is now 16 years old and received his lab-grown urethra over six years ago.

8 Mar 2011

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells.

8 Mar 2011

New Lupus drug marching towards approval

A new drug for lupus from the Human Genome Sciences Inc is all set to get clearance in the US this week. If all goes through, this drug will offer patients the first approved treatment option in a half-century, setting the manufacturer up for huge sales.

7 Mar 2011

Now get a 3-D kidney printout to replace damaged kidneys: A regeneration science innovation

In what seems like science fiction, Dr. Anthony Atala, a regenerative medicine specialist at Wake Forest University, is pioneering the use of printing techniques to reconstruct and repair human flesh and organs. His basis is a combination of cultured human cells and scaffolding built or woven from organic material.

7 Mar 2011

DaVita earns recognition in Fortune's Most Admired Companies list

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, has been honored as one of the 2011 Fortune World's Most Admired Companies, and ranked second in the Health Care: Medical Facilities industry.

5 Mar 2011

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.

5 Mar 2011

Hazardous high concentrations of cadmium found in inexpensive children's jewelry

Young children who mouth or swallow jewelry containing cadmium may be exposed to as much as 100 times the recommended maximum exposure limit for the toxic metal, according to research published online March 4 ahead of print in the peer-reviewed journal Environmental Health Perspectives (EHP). The study measured bioavailability, or how much cadmium leached out of the jewelry. The research also found that damaged pieces of jewelry in some cases leached up to 30 times more cadmium than undamaged pieces.

4 Mar 2011

Low physical activity increases kidney transplant patients' likelihood of dying early

Low physical activity increases kidney transplant patients' likelihood of dying early, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest that patients need to exercise to fend off an early death.

4 Mar 2011

Racial and ethnic groups less likely to receive kidney transplants than others

Not all racial and ethnic groups have equal access to kidney transplantation, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results indicate that the reasons for these disparities are varied and that more focused efforts are needed to address them.

3 Mar 2011

Organ transplant deaths investigated

Three women died within one week of each other after they received diseased organs in transplant procedures at the Austin and Royal Melbourne hospitals according to an ongoing inquest.

3 Mar 2011

Rockwell Medical fourth quarter net loss increases to $1.7 million

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported today fourth quarter and full-year 2010 results.

3 Mar 2011

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.

3 Mar 2011

Patients with end-stage renal disease who opt for PD experience no greater risk of catheter infection

Patients with end-stage renal disease who opt for peritoneal dialysis experience no greater risk of catheter infection than those who undergo hemodialysis, a retrospective study at UT Southwestern Medical Center has found.

3 Mar 2011

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Ken Kewley woke up Tuesday without health insurance for the first time in nearly nine years. So did most of the 41,467 other Pennsylvanians who had been covered by adultBasic, a state-subsidized insurance program for the working poor that Gov. Tom Corbett shut down on Monday in one of the largest disenrollments in recent memory.

2 Mar 2011

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research, today.

2 Mar 2011

New study to promote self-care among patients with kidney failure

A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.

2 Mar 2011

Nephrology News and Research

Further Reading

AHF unveils new national advertising campaign about AIDS drugs

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Diabetes belt mapped out in the US

Lab made urinary tube going strong after six years of transplant

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

New Lupus drug marching towards approval

Now get a 3-D kidney printout to replace damaged kidneys: A regeneration science innovation

DaVita earns recognition in Fortune's Most Admired Companies list

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

Hazardous high concentrations of cadmium found in inexpensive children's jewelry

Low physical activity increases kidney transplant patients' likelihood of dying early

Racial and ethnic groups less likely to receive kidney transplants than others

Organ transplant deaths investigated

Rockwell Medical fourth quarter net loss increases to $1.7 million

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

Patients with end-stage renal disease who opt for PD experience no greater risk of catheter infection

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

New study to promote self-care among patients with kidney failure

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News